High-Risk Secondary Myelofibrosis
Also known as: High risk Secondary Myelofibrosis
Drug | Drug Name | Drug Description |
---|---|---|
DB11697 | Pacritinib | A kinase inhibitor used for the treatment of primary and secondary myelofibrosis in adult patients with significantly reduced platelet counts. |
Drug | Drug Name | Phase | Status | Count |
---|